Cannabidiol in Anxiety and Sleep: A Large Case Series.

@article{Shannon2019CannabidiolIA,
  title={Cannabidiol in Anxiety and Sleep: A Large Case Series.},
  author={Scott M. Shannon and Nicole Lewis and Hea Eul Lee and Shannon Hughes},
  journal={The Permanente journal},
  year={2019},
  volume={23},
  pages={
          18-041
        }
}
CONTEXT Cannabidiol (CBD) is one of many cannabinoid compounds found in cannabis. [] Key MethodDESIGN A large retrospective case series at a psychiatric clinic involving clinical application of CBD for anxiety and sleep complaints as an adjunct to usual treatment. The retrospective chart review included monthly documentation of anxiety and sleep quality in 103 adult patients. MAIN OUTCOME MEASURES Sleep and anxiety scores, using validated instruments, at baseline and after CBD treatment.
View on PubMed
europepmc.org
192 Citations
Highly Influential Citations
3
Background Citations
31
Methods Citations
3
Results Citations
1

Figures and Tables from this paper

192 Citations

Cannabidiol (CBD) use in psychiatric disorders: A systematic.
Use of Cannabidiol for the Treatment of Anxiety: A Short Synthesis of Pre-Clinical and Clinical Evidence.
TLDR
Early evidence from human trials using both healthy volunteers and individuals with social anxiety disorder, suggests that CBD may have anxiolytic effects, and future research is warranted to determine the efficacy of CBD in other anxiety disorders, establish appropriate doses, and determine its long-term efficacy.
Prospects for the Use of Cannabinoids in Psychiatric Disorders
TLDR
The prospects of using the psychoactive effects of cannabinoids in treating mental and psychiatric disorders are discussed, however, this evidence is weak for some clinical conditions and well-designed randomized controlled trials are currently lacking.
Cannabinoids and Mental Health, Part 2: The Search for Clinical Applications.
  • A. Penn
  • Medicine, Psychology
    Journal of psychosocial nursing and mental health services
  • 2019
TLDR
Until additional, well-designed studies that examine the more common practice of lower doses of CBD are performed, a harm-reduction, patient-centered, empiric approach is encouraged to optimize symptom reduction while at the same time avoiding the known risks of cannabis.
Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies.
Use of cannabidiol in anxiety and anxiety-related disorders.
Cannabidiol treatment in an adolescent with multiple substance abuse, social anxiety and depression
TLDR
The patient improved regarding depressive as well as anxiety symptoms including simple phobias and symptoms of paranoia and dissociation, and the patient quit abusing illegal drugs including THC without showing withdrawal symptoms.
Cannabinoid Regulation of Fear and Anxiety: an Update
TLDR
Based on this preclinical evidence, larger-scale placebo-controlled clinical studies are warranted to investigate the effects of cannabidiol in particular as an adjunct to psychological therapy or medication to determine its potential utility for treating anxiety-related disorders in the future.
The therapeutic role of Cannabidiol in mental health: a systematic review
TLDR
CBD and CBD-containing compounds such as nabiximols were helpful in alleviating symptoms of cannabis-related disorders, schizophrenia, social anxiety disorder, and comorbidities of ASD, and ADHD with moderate recommendation, however, there is weaker evidence for insomnia, anxiety, bipolar disorder, posttraumatic stress disorder and Tourette syndrome.
Cannabinoids in the Treatment of Insomnia Disorder: A Systematic Review and Meta-Analysis
TLDR
A systematic review and meta-analysis of the literature on cannabis-based products for the treatment of insomnia disorder in adults highlights shortcomings in the existing literature, including lack of diagnostic clarity, poorly defined participant groups, non-standardised interventions and studies of inappropriate design, duration and power to detect clinically meaningful outcomes.
...
...

References

SHOWING 1-10 OF 31 REFERENCES
Cannabidiol in Humans—The Quest for Therapeutic Targets
TLDR
Preliminary clinical trials suggest that high-dose oral CBD may exert a therapeutic effect for social anxiety disorder, insomnia and epilepsy, but also that it may cause mental sedation.
Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?
TLDR
Findings suggest promising treatment effects and potentially overlapping mechanisms of action for CBD in these disorders and indicate the need for further systematic investigation of the viability of CBD as a psychiatric pharmacotherapy.
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
TLDR
CBD bears investigation in epilepsy and other neuropsychiatric disorders, including anxiety, schizophrenia, addiction, and neonatal hypoxic‐ischemic encephalopathy, however, data from well‐powered double‐blind randomized, controlled studies on the efficacy of pure CBD for any disorder is lacking.
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies
TLDR
The often described favorable safety profile of CBD in humans was confirmed and extended by the reviewed research, and the most commonly reported side effects were tiredness, diarrhea, and changes of appetite/weight.
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies
TLDR
The often described favorable safety profile of CBD in humans was confirmed and extended by the reviewed research, and some important toxicological parameters are yet to be studied, for example, if CBD has an effect on hormones.
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
TLDR
The increase in anxiety induced by the SPST on subjects with SAD was reduced with the use of CBD, resulting in a similar response as the HC, and no significant differences were observed between CBD and HC in SSPS-N scores or in the cognitive impairment, discomfort, and alert factors of VAMS.
Effects of ipsapirone and cannabidiol on human experimental anxiety
TLDR
The results suggest that ipsapirone and CBD have anxiolytic properties in human volunteers submitted to a stressful situation.
Cannabis in painful HIV-associated sensory neuropathy
TLDR
Smoked cannabis was well tolerated and effectively relieved chronic neuropathic pain from HIV-associated sensory neuropathy and the findings are comparable to oral drugs used for chronic Neuropathic pain.
Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …
TLDR
Physicians need to be educated on the history, pharmacology, clinical indications, and proper clinical use of cannabis, as patients will inevitably inquire about it for many diseases, including chronic pain and headache disorders for which there is some intriguing supportive evidence.
Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
TLDR
The results confirmed that the acute administration of CBD induced anxiolytic effects with a dose-dependent inverted U-shaped curve in healthy subjects, since the subjective anxiety measures were reduced with CBD 300 mg, but not with CBD 100 and 900 mg, in the post-speech phase.
...
...